Skip to content

Meta-Analysis: The Use of Mindfulness-Based Cognitive Therapy for Depression Symptoms

Made Arisudana, Ananta Yudiarso

Bulletin of Counseling and Psychotherapy June 1, 2024 DOI: 10.51214/00202406894000 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Meta-analysis Peer reviewed
Intervention Mindfulness-Based Cognitive Therapy (MBCT)
Measures Depression Anxiety and Stress Scale (DASS), Beck Depression Inventory (BDI)
Topics Depression Meditation
Key findings The authors conclude that MBCT is associated with reduced depressive symptoms, with full program completion, participant-tailored materials, mindful awareness, and cognitive restructuring highlighted as key factors. Moderator analysis found no significant difference between in-person and internet-based MBCT delivery, and consistent participation and mindfulness practice are emphasized for successful outcomes.

Abstract

This meta-analysis investigates the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in addressing depression across diverse contexts. Drawing from 13 studies, it examines the impact of MBCT on depressive symptoms using various measurement tools such as the Depression Anxiety and Stress Scale (DASS) and Beck-Depression Inventory (BDI). The findings underscore the importance of tailoring intervention materials to participant characteristics and completing the full MBCT program for significant outcomes. Additionally, components of MBCT, such as mindful awareness and cognitive restructuring, emerge as key factors in reducing depressive symptoms. Moderator analysis reveals no significant difference between in-person and internet-based MBCT delivery, highlighting the importance of consistent participation and mindfulness practice for successful outcomes.

Comparable studies

Other systematic reviews and meta-analyses on depression, most cited first.

Study Year Design Participants
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression Participants with major depression in placebo-controlled, double-blind, randomized... 2015 Systematic review and meta-analysis
Side-effects associated with ketamine use in depression: a systematic review. Patients with depression 2018 Systematic review
Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis Adults with unipolar or bipolar major depression 2020 Systematic review and meta-analysis n = 1,877
Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories Patients with major depressive disorder or bipolar depression 2016 Systematic review and meta-analysis n = 588
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Patients with cancer- or illness-related anxiety and depression, major depressive... 2020 Systematic review n = 188

Citations in the library

Explore topics